FindTrial
Sign In

Screening and molecular diagnosis-based individualized precision management of monogenic diabetes

Screening and molecular diagnosis-based individualized precision management of monogenic diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070147
Enrollment
Unknown
Registered
2023-04-03
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monogenic diabetes

Interventions

Early-onset diabetes individuals:No interventions

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Onset of diabetes before 25 years of age,or onset of diabetes before 35 years of age, with 2 or more immediate relatives are diagnosed with diabetes before the age of 45; 3. BMI<28kg/m2; 3.Persons with autoantibody(GAD-Ab or ICA-Ab or IAA-Ab)-negative diabetes.

Exclusion criteria

Exclusion criteria: 1. Secondary diabetes mellitus;Patients with other endocrine diseases, such as hyperthyroidism or hypothyroidism, hyperparathyroidism or hypothyroidism, acromegaly, Cushing's syndrome, autoimmune multiple endocrine diseases, etc; 2.Systemic use of glucocorticoids, immunosuppressants, or other drugs within the past 6 months; 3.Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
Prevalence of monogenic diabetes;—

Secondary

MeasureTime frame
Diabetes autoantibody;liver function;blood fat;Glucose tolerance;—

Countries

China

Contacts

Public ContactMingLiu

Tianjin Medical University General Hospital

mingliu@tmu.edu.cn+86 18322017516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026